Press Releases

September 18, 2009 Lupin ties up with leading Institutes for PhD Program

July 29, 2009 Lupin Net Profit up by 25 % in Q1, FY 2009-10 Outpacing and Outperforming Markets globally

June 30, 2009 Lupin Expands Branded Play Announces Acquisition of Worldwide Rights for its first NDA – AllerNaze™

May 13, 2009 Lupin Q4 & FY 2008-09 Results – Consistent Performance & Solid Growth

May 11, 2009 Lupin Announces Litigation Settlement with Wyeth for Venlafaxine Extended Release Capsules

April 9, 2009 Alliance to commercialize generic equivalent of FOSRENOL® Tablets

March 26, 2009 Lupin acquires majority stake in Multicare Pharmaceuticals Philippines, Inc.

January 29, 2009 Lupin Q3 FY 08-09 – Strong Growth & Consistent Performance

January 16, 2009 Lupin receives USFDA approval for Levetiracetam Tablets